Capricor Therapeutics | CAPR - Ebitda


Capricor Therapeutics reported $-27.23M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Bioline Rx USD -554K 2.93M Sep/2025
Capricor Therapeutics USD -27.23M 2.66M Jun/2025
Cipla INR 12.55B 6.4B Dec/2025
Cytokinetics USD -149.83M 127.34M Dec/2025
Geron USD -9.47M 1.92M Sep/2025
Grifols EUR 482.04M 7.04M Sep/2025
Immunic USD -22.78M 753K Jun/2024
J&J USD 7.19B 2.32B Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Prothena USD -39.53M 12.25M Sep/2025
PTC Therapeutics USD -70.99M 91.62M Dec/2025
Sarepta Therapeutics USD -168.03M 294.45M Sep/2025